Care-coordination platform built on AI detection modules across stroke and other time-critical conditions; holds the first and only FDA clearance for automated subdural hematoma measurement.
Multiple FDA clearances, including the first for automated subdural hematoma measurement.
Company press release marking its 10th anniversary, self-reporting ‘2,000 hospitals and 230 million patients’.
Not found in this research pass — this figure is vendor-reported only; verify before publishing.
Vendor claims 2,000 hospitals / 230 million patients reached over 10 years — the largest scale claim found in this scan, but self-reported and not yet independently audited.
Scale figure comes from a company press release, not a third-party audit or peer-reviewed source.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.